Background Be Aims: Tobacco smoking has a complex effect on intestinal infl
ammation, being protective in ulcerative colitis, whereas it aggravates Cro
hn's disease. The beneficial effect of smoking has been attributed to nicot
ine, but the mechanisms underlying the adverse effect are still under inves
tigation. The aim of this study was to examine the effect of cigarette smok
ing on experimental colitis in rats and to investigate the underlying mecha
nism. Methods: Rats were exposed daily to cigarette smoke by means of a spe
cialized smoking chamber. Control rats were placed in the same chamber with
out introducing smoke. In parallel experiments, rats received the ganglioni
c blocker hexamethonium before smoke exposure. After 2 weeks, colitis was i
nduced by dinitrobenzenesulfonic acid (DNBS), and inflammation was assessed
3 days later. Results: Exposure to cigarette smoke significantly increased
macroscopic and histological damages as well as myeloperoxidase activity c
ompared with sham-treated controls. Treatment with hexamethonium before smo
king reversed the effect of the smoke on the colitis, improving all paramet
ers. Conclusions: Exposure to cigarette smoke aggravates DNBS-induced colit
is in the rat. This effect is reversed by hexamethonium, suggesting that a
neural pathway is involved.